Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is specialized in R&D and production of APIs and advanced intermediates. With 22 years of production experience,the company has ...
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
About the Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Sweden
Brand Name : Chirocaine
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 0.625 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Chirocaine
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 1.25 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Chirocaine
Dosage Form : INJECTION / CONCENTRATE FOR
Dosage Strength : 5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Chirocaine
Dosage Form : INJECTION / CONCENTRATE FOR
Dosage Strength : 2.5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Chirocaine
Dosage Form : INJECTION / CONCENTRATE FOR
Dosage Strength : 7.5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Levobupivacaine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levobupivacaine, including repackagers and relabelers. The FDA regulates Levobupivacaine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levobupivacaine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levobupivacaine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levobupivacaine supplier is an individual or a company that provides Levobupivacaine active pharmaceutical ingredient (API) or Levobupivacaine finished formulations upon request. The Levobupivacaine suppliers may include Levobupivacaine API manufacturers, exporters, distributors and traders.
click here to find a list of Levobupivacaine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levobupivacaine DMF (Drug Master File) is a document detailing the whole manufacturing process of Levobupivacaine active pharmaceutical ingredient (API) in detail. Different forms of Levobupivacaine DMFs exist exist since differing nations have different regulations, such as Levobupivacaine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levobupivacaine DMF submitted to regulatory agencies in the US is known as a USDMF. Levobupivacaine USDMF includes data on Levobupivacaine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levobupivacaine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levobupivacaine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levobupivacaine Drug Master File in Japan (Levobupivacaine JDMF) empowers Levobupivacaine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levobupivacaine JDMF during the approval evaluation for pharmaceutical products. At the time of Levobupivacaine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levobupivacaine suppliers with JDMF on PharmaCompass.
A Levobupivacaine written confirmation (Levobupivacaine WC) is an official document issued by a regulatory agency to a Levobupivacaine manufacturer, verifying that the manufacturing facility of a Levobupivacaine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levobupivacaine APIs or Levobupivacaine finished pharmaceutical products to another nation, regulatory agencies frequently require a Levobupivacaine WC (written confirmation) as part of the regulatory process.
click here to find a list of Levobupivacaine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levobupivacaine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levobupivacaine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levobupivacaine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levobupivacaine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levobupivacaine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levobupivacaine suppliers with NDC on PharmaCompass.
Levobupivacaine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levobupivacaine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levobupivacaine GMP manufacturer or Levobupivacaine GMP API supplier for your needs.
A Levobupivacaine CoA (Certificate of Analysis) is a formal document that attests to Levobupivacaine's compliance with Levobupivacaine specifications and serves as a tool for batch-level quality control.
Levobupivacaine CoA mostly includes findings from lab analyses of a specific batch. For each Levobupivacaine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levobupivacaine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levobupivacaine EP), Levobupivacaine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levobupivacaine USP).
LOOKING FOR A SUPPLIER?
